Table 3.
Logistic regression analysis of variables associated with the severity of COVID-19.
Variables | Univariate analysis |
Multivariate analysis |
||||
---|---|---|---|---|---|---|
OR | 95%CI | P value | OR | 95%CI | P value | |
Age(years) | 1.037 | 0.997-1.079 | 0.068 | |||
BMI (kg/m2) | 1.186 | 1.029-1.367 | 0.019 | |||
Hypertension | 5.201 | 1.745-15.508 | 0.003 | 4.380 | 1.012-18.993 | 0.048 |
WBC count (×109) | 1.009 | 0.845-1.206 | 0.917 | |||
Neutrophil% (%) | 1.062 | 1.012-1.116 | 0.015 | |||
Lymphocyte% (%) | 0.932 | 0.877-0.989 | 0.021 | |||
Neutrophil count (×109/L) | 1.054 | 0.906-1.226 | 0.497 | |||
Lymphocyte count (×109/L) | 0.160 | 0.041-0.632 | 0.009 | |||
Platelet count (×109/L) | 0.990 | 0.980-1.000 | 0.041 | |||
NLR | 1.090 | 1.003-1.185 | 0.043 | |||
PLR | 1.004 | 1.000-1.008 | 0.06 | |||
D-dimer (ng/ml)* | 0.899 | 0.998-1.002 | 0.899 | |||
Fibrinogen (mg/dl) | 1.004 | 1.001-1.008 | 0.007 | |||
Erythrocyte sedimentation rate (mm/h)a | 1.015 | 0.996-1.034 | 0.118 | |||
Sialic acid (U/L) | 1.049 | 1.011-1.088 | 0.011 | |||
C-reactive protein (mg/L) | 1.033 | 1.015-1.052 | <0.001 | 1.030 | 1.005-1.055 | 0.017 |
Interleukin-2 (pg/ml) | 0.790 | 0.389-1.604 | 0.515 | |||
interleukin-4 (pg/ml) | 1.020 | 0.529-1.967 | 0.952 | |||
Interleukin-6 (pg/ml) | 1.086 | 1.041-1.133 | <0.001 | 1.090 | 1.040-1.147 | <0.001 |
Interleukin-10(pg/ml) | 1.117 | 1.017-1.228 | 0.021 | |||
Interferon-γ (pg/ml) | 0.994 | 0.947-1.043 | 0.803 | |||
Tumor Necrosis Factor-α (pg/ml) | 0.917 | 0.386-2.182 | 0.845 |
COVID-19: coronavirus disease 2019; WBC: white blood cell; NLR: neutrophil-to-lymphocyte ratio; PLR: platelet-to-lymphocyte ratio; OR: odd ratio; CI: confidence interval.
The number of COVID-19 patients who tested D-dimer was 95 and 10 in the non-severe group and severe group, respectively.
The number of COVID-19 patients who tested erythrocyte sedimentation rate was 97 and 12 in the non-severe group and severe group, respectively.